[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024.
WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has provided [...] Read more »
Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
MNV–201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria
In pre–clinical studies, MNV–201 [...] Read more »
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month.
Read more »
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader Read more »
Fortrea lance un studio d’innovation en IA pour galvaniser les solutions technologiques et humaines afin d’améliorer la réalisation des essais cliniques
DURHAM, État de Caroline du Nord, 28 juin 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a [...] Read more »
Fortrea startet KI-Innovationsstudio, um Technologie und menschliche Lösungen zur Verbesserung der Durchführung klinischer Studien zu bündeln
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), ein führendes globales Auftragsforschungsinstitut (CRO), gab heute die Einführung seines Innovationsstudios für künstliche Intelligenz (KI) [...] Read more »
Fortrea Lança AI Innovation Studio para Galvanizar Tecnologia e Soluções Humanas para Aprimoramento da Entrega de Ensaios Clínicos
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) — A Fortrea (Nasdaq: FTRE), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje o lançamento do seu AI Innovation Studio, [...] Read more »
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a [...] Read more »
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) — The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most [...] Read more »
Para Reforçar os Esforços Globais no Combate às Bactérias Resistentes a Antibióticos, Cientistas do KFSH&RC Descobrem Nova Espécie de Bactéria: Riyadhensis
RIADE, Arábia Saudita, March 26, 2024 (GLOBE NEWSWIRE) — Em um desenvolvimento revolucionário, cientistas do King Faisal Specialist Hospital and Research Centre (KFSH&RC) identificaram uma [...] Read more »
Im Rahmen der weltweiten Bemühungen zur Bekämpfung antibiotikaresistenter Bakterien entdecken KFSH&RC‑Wissenschaftler die neue Bakterienspezies: Riyadhensis
RIAD, Saudi–Arabien, March 26, 2024 (GLOBE NEWSWIRE) — In einer bahnbrechenden Entwicklung haben Wissenschaftler des King Faisal Specialist Hospital and Research Centre (KFSH&RC) durch [...] Read more »
Les scientifiques de l’hôpital spécialisé et centre de recherche King Faisal contribuent aux efforts internationaux de lutte contre l’antibiorésistance des bactéries en identifiant une toute nouvelle espèce de bactérie : Riyadhensis
RIYAD, Arabie saoudite, 26 mars 2024 (GLOBE NEWSWIRE) — Des scientifiques de l’hôpital spécialisé et centre de recherche King Faisal (ou [...] Read more »
To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis
RIYADH, Saudi Arabia, March 25, 2024 (GLOBE NEWSWIRE) — In a ground–breaking development, scientists at King Faisal Specialist Hospital and Research Centre (KFSH&RC) have identified a [...] Read more »
لتعزيز الجهود العالمية لمكافحة البكتيريا المقاومة للمضادات الحيوية علماء في التخصصي .. يكتشفون نوعاً جديداً من البكتيريا باسم “رياض نسيس”
الرياض, March 25, 2024 (GLOBE NEWSWIRE) —
اكتشف [...] Read more »